Kyntra Bio Inc share price logo

Kyntra Bio Inc Share Price

NASDAQ: KYNB

Small Cap

$6.99

-0.06

(-0.85%)

Live

as on

Kyntra Bio Inc Stock Performance

as on March 4, 2026 at 5:43 am IST

  • Day's Low

    Day's High

    $6.72
    $7.05
    downward going graph

    3.86%

    Downside

    0.86%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Kyntra Bio Inc share price movements today

Previous Close
$7.05
Open
$6.94
Volume
236.5K
Day's Low - High
$6.72 - $7.05

Kyntra Bio Inc Historical Returns

1 Month Return
-17.06 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Kyntra Bio Inc Stock Fundamentals & Key Indicators

Check Kyntra Bio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$28.0M

EPS (TTM)

-4.605

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Kyntra Bio Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kyntra Bio Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Kyntra Bio Inc image
Kyntra Bio Inc
NA$28.0MNANA2598.87%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$126.2B133.18%32.4732.94%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$44.2B125.24%142.888.45%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$35.1BNA621.555.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$82.6B77.02%18.8331.41%

Kyntra Bio Inc Stock’s Investor Sentiment and Interest

Search interest for Kyntra Bio Inc Stock has decreased by -47% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-47% versus previous 30 day period

Kyntra Bio Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
44
40
27
25
0
46
-123
2
1
1
Gross Profit
38
35
21
-32
-31
41
-102
2
1
1
Operating Income
-88
-63
-54
-49
-46
-16
-91
-14
-12
-5
EBITDA
-82
-56
-49
-48
-45
-12
-91
-14
-11
-10
Interest Expense
3
5
5
2
1
4
2
2
2
2
Depreciation
-
-
-
-
-
0
0
0
0
0
Income Before Tax
-87
-63
-56
-49
-47
-17
-87
-16
-13
-13
Income Tax Expense
0
0
0
0
0
0
0
0
0
-
Net Income
-87
-63
-56
-32
-15
-17
17
4
-7
200
Net Profit Margin
-197.84%
-158.51%
-207.21%
-129.84%
-1557.52%
-36.87%
-14.59%
169.37%
-564.02%
18646.47%

Kyntra Bio Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
180
179
125
212
256
176
235
140
46
29
Gross Profit
-33
-7
-70
-22
255
167
-213
120
42
14
Operating Income
-77
-53
-122
-86
-89
-191
-288
-301
-322
-150
EBITDA
-68
-44
-104
-68
-52
-164
-333
-282
-305
-142
Interest Expense
11
10
9
10
2
2
1
1
8
8
Depreciation
-
-
-
-
-
-
14
10
9
2
Income Before Tax
-85
-61
-125
-86
-76
-188
-289
-293
-323
-153
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-85
-61
-126
-86
-76
-189
-290
-293
-284
-47
Net Profit Margin
-47.44%
-34.35%
-100.43%
-40.58%
-30.00%
-107.36%
-123.25%
-208.66%
-607.29%
-160.63%

Kyntra Bio Inc Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-63
-56
-32
-15
-17
17
4
-7
-13
Operating Cash Flow
-84
-18
-59
-39
-8
-30
2
12
-1
Investing Cash Flow
54
10
51
72
0
1
0
0
87
Financing Cash Flow
0
0
0
0
0
0
0
0
-85
Change in Cash
-31
-7
-7
34
-9
-28
4
13
94

Kyntra Bio Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-58
-120
-86
-76
-189
-290
-293
-284
-47
Operating Cash Flow
7
-66
-76
-78
81
-82
-145
-315
-137
Investing Cash Flow
6
69
-522
120
452
-426
89
153
125
Financing Cash Flow
6
496
13
-4
13
0
46
122
0
Change in Cash
20
499
-584
37
552
-507
-15
-42
-11

Insights on Kyntra Bio Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -7.60M → 200.63M (in $), with an average increase of 103.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 33.5% return, outperforming this stock by 59.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 60.5% return, outperforming this stock by 159.2%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 2.73M → 1.07M (in $), with an average decrease of 35.5% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, KYNB stock has moved down by -98.7%

About Kyntra Bio Inc

FibroGen, Inc. is a biopharmaceutical company focused on the development of novel therapies at the frontiers of cancer biology and anemia. It is developing FG-3246, a potential first-in-class antibody-drug conjugate (ADC) targeting CD46, for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and potentially other cancers. This program also includes the development of FG-3180, an associated CD46-targeted positron emission tomography (PET) biomarker and imaging agent. It is also developing Roxadustat, an oral medication, first-in-class, oral small molecule hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), which is evaluated for the treatment of anemia in patients with chronic kidney disease (CKD), anemia associated with myelodysplastic syndromes and chemotherapy-induced anemia. Roxadustat is approved in China, Europe, Japan, and numerous other countries for the treatment of anemia of CKD in adult patients on dialysis (DD) and not on dialysis (NDD).
OrganisationKyntra Bio Inc
Headquarters350 Bay Street, San Francisco, CA, United States, 94133
CEOMr. Thane Wettig
E-voting on sharesClick here to vote

Key Management of Kyntra Bio Inc

Name

Title

Mr. Thane Wettig

CEO & Director

Mr. David DeLucia

Senior VP & CFO

Mr. John Alden

Corporate Secretary & General Counsel

Ms. Gaia Vasiliver-Shamis

Director of IR & Communications - LifeSci Advisors

FAQs

What is Kyntra Bio Inc share price today?

Kyntra Bio Inc share price today is $6.99 as on . Kyntra Bio Inc share today touched a day high of $7.05 and a low of $6.72.

What is the 52 week high and 52 week low for Kyntra Bio Inc share?

Kyntra Bio Inc share touched a 52 week high of $ on and a 52 week low of $ on . Kyntra Bio Inc stock price today i.e. is trending at $6.99,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Kyntra Bio Inc's market capitalisation today?

Kyntra Bio Inc market capitalisation is $0.00T as on .

How to invest in Kyntra Bio Inc Stock (KYNB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kyntra Bio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kyntra Bio Inc Shares that will get you 0.2146 shares as per Kyntra Bio Inc share price of $6.99 per share as on March 4, 2026 at 12:13 am IST.

What is the minimum amount required to buy Kyntra Bio Inc Stock (KYNB) from India?

Indian investors can start investing in Kyntra Bio Inc (KYNB) shares with as little as ₹92.074 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹920.74 in Kyntra Bio Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Kyntra Bio Inc share’s latest price of $6.99 as on March 4, 2026 at 12:13 am IST, you will get 1.4306 shares of Kyntra Bio Inc. Learn more about fractional shares .